Theravance Drug Fails Another Pivotal Test, This Time Sparking Restructuring That Ends R&D
Ampreloxetine’s Section 3 failure in a number of system atrophy is the third disappointing medical trial end result for the ...
Ampreloxetine’s Section 3 failure in a number of system atrophy is the third disappointing medical trial end result for the ...
The outcomes of a randomized managed trial (RCT) point out that meningococcal B vaccine isn't efficient at stopping gonorrhea an ...
A new UCLA study reveals that a widely used federal hospital safety metric is fundamentally flawed when applied to emergency ...
Frerieke / Flickr cc A randomized clinical trial finds that the anti-inflammatory drug colchicine, once thought promising for treating COVID-19, ...
An experimental drug from Alector Inc. failed to slow the decline of patients with frontotemporal dementia in a late-stage study, ...
A Bristol Myers Squibb drug whose landmark FDA approval introduced the first novel mechanism for treating schizophrenia in decades has ...
In 2013, Google announced it would attempt to understand and ultimately slow aging through a company called Calico, a moonshot ...
Credit: Pixabay/CC0 Public Domain The U.S. is failing to keep pace with dozens of countries around the world due to ...
Alector Therapeutics said Monday that its Phase 2 trial for an experimental Alzheimer’s antibody failed, dealing a blow to what ...
Copyright © 2025 Your Health 24 7.
Your Health 24 7 is not responsible for the content of external sites.
Copyright © 2025 Your Health 24 7.
Your Health 24 7 is not responsible for the content of external sites.